NIH-funded research R01 grant

Using modified mRNA to improve healing of diabetic foot ulcers

Official title: Use of Modified mRNA for the Treatment of Diabetic Foot Ulceration

Funded at Beth Israel Deaconess Medical Center · NIH-11077275 · Data updated 2026-11-12

This study is looking at how special bandages that use modified mRNA can help heal diabetic foot ulcers better, making it easier for people with diabetes to recover from these tough wounds.

More Diabetic Foot research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBeth Israel Deaconess Medical Center
NIH-funded
Lab location1 site (Boston, United States)
Project startApril 19, 2024
Project endMarch 31, 2028
Funding year2025
Award (this year)$734,549
NIH project number5R01DK136699-02
Project IDNIH-11077275 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with diabetes who are experiencing foot ulcers and have not responded well to standard treatments.

Less likely to help

Patients with foot ulcers not related to diabetes or those who have other underlying conditions affecting wound healing may not benefit from this research.

What this research studies

This research investigates how modified mRNA can be used to enhance the healing process of diabetic foot ulcers, a common and serious complication for individuals with diabetes. By analyzing the molecular characteristics of healing and non-healing ulcers, the study aims to identify key factors that promote wound healing. The researchers are developing specialized alginate bandages that can deliver these modified mRNAs directly to the wound site, potentially improving healing outcomes. The approach involves a combination of different mRNAs delivered in a specific sequence to mimic natural healing processes.

Why it matters

Potential benefit: If successful, this research could lead to new, effective treatments for diabetic foot ulcers, reducing the risk of complications such as infections and amputations.

How similar studies have gone: Other research has shown promise in using mRNA therapies for wound healing, indicating that this approach could be a viable and innovative treatment option.

Where this research is happening

  • Beth Israel Deaconess Medical Center
    Boston, United States
    Active

Researchers

  • Principal investigator: Veves, Aristidis — Beth Israel Deaconess Medical Center
  • Study coordinator: Veves, Aristidis

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.